Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 4
2014 15
2015 21
2016 24
2017 23
2018 35
2019 41
2020 31
2021 24
2022 34
2023 32
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Results by year

Filters applied: . Clear all
Page 1
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jäger U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak Ö, Salles G, Maziarz RT; JULIET Investigators. Schuster SJ, et al. N Engl J Med. 2019 Jan 3;380(1):45-56. doi: 10.1056/NEJMoa1804980. Epub 2018 Dec 1. N Engl J Med. 2019. PMID: 30501490 Clinical Trial.
Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy.
Steinhelfer L, Lunger L, Cala L, Pfob CH, Lapa C, Hartrampf PE, Buck AK, Schäfer H, Schmaderer C, Tauber R, Brosch-Lenz J, Haller B, Meissner VH, Knorr K, Weber WA, Eiber M. Steinhelfer L, et al. Among authors: lapa c. J Nucl Med. 2024 Jan 2;65(1):79-84. doi: 10.2967/jnumed.123.265986. J Nucl Med. 2024. PMID: 37857504
Foreword.
Lapa C, Bundschuh RA. Lapa C, et al. Nuklearmedizin. 2022 Jun;61(3):222. doi: 10.1055/a-1819-9945. Epub 2022 Jun 3. Nuklearmedizin. 2022. PMID: 35668667 No abstract available.
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: lapa c. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Clinical Trial.
Infection and Inflammation Imaging: Beyond FDG.
Kircher M, Lapa C. Kircher M, et al. Among authors: lapa c. PET Clin. 2020 Apr;15(2):215-229. doi: 10.1016/j.cpet.2019.11.004. Epub 2020 Feb 11. PET Clin. 2020. PMID: 32145892 Review.
New PET Tracers for Lymphoma.
Enke JS, Bundschuh RA, Claus R, Lapa C. Enke JS, et al. Among authors: lapa c. PET Clin. 2024 Oct;19(4):463-474. doi: 10.1016/j.cpet.2024.05.002. Epub 2024 Jul 4. PET Clin. 2024. PMID: 38969567 Review.
CXCR4-directed theranostics in oncology and inflammation.
Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C. Kircher M, et al. Among authors: lapa c. Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Ann Nucl Med. 2018. PMID: 30105558 Free PMC article. Review.
In Vivo Targeting of CXCR4-New Horizons.
Schottelius M, Herrmann K, Lapa C. Schottelius M, et al. Among authors: lapa c. Cancers (Basel). 2021 Nov 25;13(23):5920. doi: 10.3390/cancers13235920. Cancers (Basel). 2021. PMID: 34885030 Free PMC article. Review.
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Werner R, Haug A, Buske C, Heidegger S, Illert AL, Bassermann F, Herhaus P, Buck A, Duell J, Topp MS, Kraus S, Einsele H, Lapa C, Raderer M, Lenz G, Habringer S, von Tresckow B, Keller U. Werner R, et al. Among authors: lapa c. Nuklearmedizin. 2024 Apr;63(2):57-61. doi: 10.1055/a-2194-9965. Epub 2024 Jan 8. Nuklearmedizin. 2024. PMID: 38190998 Free PMC article.
275 results